The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
about
Chemokines and Chemokine Receptors in the Development of Lupus NephritisDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsGraft rejection - endogenous or allogeneic?Biological interplay between proteoglycans and their innate immune receptors in inflammationInsights into the key roles of proteoglycans in breast cancer biology and translational medicineSignaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21The pathogenesis, diagnosis and treatment of lupus nephritis.Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologySerum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalinSoluble biglycan induces the production of ICAM-1 and MCP-1 in human aortic valve interstitial cells through TLR2/4 and the ERK1/2 pathway.Soluble biglycan as a biomarker of inflammatory renal diseases.Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr miceAxonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation.Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them.Escape from X inactivation varies in mouse tissues.Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivoThe interplay of extracellular matrix and microbiome in urothelial bladder cancer.A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs.The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetesLymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndromeTrastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancerDecorin: a guardian from the matrixThe small leucine-rich repeat proteoglycans in tissue repair and atherosclerosisCyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritisBiglycan: a multivalent proteoglycan providing structure and signalsAn introduction to proteoglycans and their localizationAge-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.Enhanced biglycan gene expression in the adipose tissues of obese women and its association with obesity-related genes and metabolic parameters.CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesisBiglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants.Immunopathology of lupus nephritis.Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?
P2860
Q26741199-9EBD206E-5BC4-49F7-86D7-C20DA4762AE4Q26801397-A725D257-1B2E-44CB-B5D6-11FBB069D21FQ26866523-FEDC3CF5-8E68-482A-B150-A3B96839E07AQ27005610-EBA9DF50-F337-43C7-A3EB-CBBCF6805DA8Q28085548-975C2072-AD97-4E86-A628-EA54C1960E33Q28253084-9C7A198D-004F-4D8E-A17B-FBAFFD8DE7B4Q30596968-979870D4-FEC2-4542-BD52-46B89FCF428BQ33752945-69CEA294-708C-47B2-B7EB-393AD9279E26Q33819300-49FA4429-E4AD-43AC-A83E-A5BD9982E3D8Q33992328-1B76E812-5F60-4C3F-A649-EF0557161FE3Q34051570-7FA9B77E-F87A-4DFE-BF72-60C22BAD1941Q34160971-C9CFDB7F-DA4A-449E-BA8D-205B5BFE28A1Q34602046-8B3C5334-F9D2-43E4-9EB6-4448605A6AB3Q35004877-B3CE5C9E-945C-49B1-B83E-82161C52C5A6Q35140044-399CCF3C-71E8-49AF-A84F-5D1BA374EDA6Q35147045-24FAF212-B9C2-4FB3-94C1-6939D7BA72DBQ35191969-E3B40B54-D081-4BCD-B974-85DF62E2366CQ35571926-DB6D0FFC-806D-4684-B5EF-4FE3F843884AQ35868405-18A31D4F-C1BD-4BB9-B32E-086D2F3743A4Q35888109-C82D3937-E8C3-4E8B-A2AF-A611D421F3AFQ35905949-55EA88DF-CAAF-47AF-9705-6EEE802030E4Q35907701-7DA2D01B-DE12-458F-8D53-DD043EDD1A6AQ35934478-9FCD5DC6-51CF-4C64-8D09-BCCFC586BD7DQ36012754-400162D2-1D58-450A-BC97-667344621F17Q36020284-5ACE8927-95C6-4468-9C9B-18BACA12F221Q36090335-B407E4C8-45C9-46B8-93F5-9D7370D39F46Q36131541-C845E677-F192-44EF-A12D-E92CF0F74BE8Q36192960-D1F200E6-0765-4277-A45C-81AC1E652D50Q36218400-3C500093-2293-43E8-ACC9-BBCC5AC1A8A9Q36477482-5AEA34A1-0B1A-4672-89D3-765AFD21D969Q36481626-1AFA6E13-0351-49FD-BC97-4C2A7DC90698Q36481630-D8FAD2A0-3F2B-46E5-BE20-92CD8463EB24Q37123896-B324AF45-3A3C-4A7D-B065-1AF9DECC8C31Q37134816-851B18B1-A488-4B8B-8994-3B2DEB6B9CCBQ37238275-7391DA1D-E66D-48E1-996A-5EAB011B51D4Q37729228-8F2B7F65-D815-45F6-9517-C4CB56BE2E8EQ38176819-D0CEA44A-FC06-4B37-8F0F-E2BDB10CA3D6Q38196396-11E2977F-A34D-447B-A3D3-021B3B2E0735Q38206875-1656B4D2-1397-4B29-A4A3-146CEF94F062Q38241317-D00BD4F2-3570-45F0-8424-C441A5A79500
P2860
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@ast
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@en
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@nl
type
label
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@ast
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@en
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@nl
prefLabel
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@ast
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@en
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@nl
P2093
P2860
P356
P1476
The proteoglycan biglycan regu ...... avates murine lupus nephritis.
@en
P2093
Andrea Babelova
Jinyang Zeng-Brouwers
Josef Pfeilschifter
Kristin Moreth
Liliana Schaefer
Marian F Young
Norbert Gretz
Rebekka Brodbeck
Roland M Schaefer
Tilmann Spieker
P2860
P304
P356
10.1172/JCI42213
P407
P577
2010-11-15T00:00:00Z